Navigation Links
Induced Pluripotent Stem Cell Industry (iPSC Market) Report Updated for 2013 Now Available at ReportsnReports.com
Date:6/13/2013

Dallas, Texas (PRWEB) June 13, 2013

Sales (number) of iPSC research products worldwide have been growing at a rate of 14.7% per year for the past five years. In addition, 22% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project. It is clear that iPSCs are a vital research trend within the scientific community. A distinctive feature of this report is an end-user survey of 293 researchers (181 U.S. / 112 International) that identify as having induced pluripotent stem cells as their core research focus. These survey findings reveal iPSC researcher needs, technical preferences, key factors influencing buying decisions, and more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report” on market metrics, dynamics, and trends says continued research and experimentation has resulted in numerous advances over the last few years. In one example, the University of Michigan announced in “Circulation Research” (2012) that they had developed innovative methods for use of induced pluripotent stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment quickly fueled other research into the use of iPSCs for the reversal and repair of diseased heart tissue. Similar advances will continue to be perfected for use of reprogrammed adult cells in the treatment of other diseases and disorders. Original techniques for iPSC production, such as viral induced transcription processes, are being replaced with newer technologies as private industries join with the scientific community to develop safe and efficient methods of iPSC productio
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Risk of CT-induced cancer minimal compared to risk of dying from disease
2. Induced Labor Late in Pregnancy Has Pros, Cons
3. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
4. Nocebo: Induced to be ill
5. Report: Strategies to prevent noise-induced hearing loss, tinnitus in soldiers
6. Immediate health risk must be weighed against radiation-induced cancer risk
7. Hearing Restored in Mice With Noise-Induced Deafness
8. Silibinin, found in milk thistle, protects against UV-induced skin cancer
9. Cooling may prevent trauma-induced epilepsy
10. ATS publishes clinical practice guidelines on exercise-induced bronchoconstriction
11. New therapy target for kids fever-induced seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... 19, 2014 Silver Dollar City ... record -- for the first time ever, Silver Dollar City ... Guinness World Records 2015, listing the park’s wood coaster Outlaw ... In additional awards announced this week, Silver Dollar City is ... in the US,” USA Today’s 10Best awards for “Best Public ...
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... An evening dress is perfect for any occasion and ... distinguished dresses retailer, has unveiled its new selection of evening ... great shopping platform. Customers can view more at ... has been accepted and praised by customers for many years. ... for clients. In order to expand its market share, the ...
(Date:12/19/2014)... The print component of Vision and Hearing is ... Toronto Star, with a circulation of approximately 230,433 copies ... is distributed nationally through a vast social media strategy ... partner outlets. To explore the digital version of the ... an exclusive interview with Mark DeMontis , sharing ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... investigators Lewis C. Cantley, PhD, and Cornelius P. Terhorst, PhD, ... American Association for the Advancement of Science. They are ... distinguished efforts to advance science, and will be honored during ... BIDMC,s Division of Signal Transduction and Director of the BIDMC ...
... This release is available in German . ... of recovery depending on disease stage. Experts hope that the ... is more helpful in the choice of the right treatment ... for Quality and Efficiency in Health Care (IQWiG) has now ...
... 2011 HIV-positive head and neck cancer patients respond ... rates as non-HIV-positive patients, despite prior reports to the ... of the International Journal of Radiation OncologyBiologyPhysics , ... Oncology (ASTRO). , Patients with HIV have a significantly ...
... The combined results of a genetic blood test and ... of healthy older adults, many of whom were destined ... John Woodard, Ph.D., associate ... and Sciences and Institute of Gerontology at Wayne State ...
... (Jan. 19, 2011) A new program designed to create ... Colorado has received a $3.9 million grant from the Colorado ... four-year program housed in the Department of Family Medicine at ... brings together local and national leaders from the mental health, ...
... Dotinga HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay ... that aims to reveal the presence of Alzheimer,s disease, potentially ... early stages. Another study finds that blood tests could indicate ... there,s a catch: Alzheimer,s disease is not curable, and existing ...
Cached Medicine News:Health News:Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable 2Health News:HIV-positive head and neck cancer patients benefit from radiation therapy 2Health News:Wayne State University study predicts risk of memory loss in healthy, older adults 2Health News:New program targeting whole-person health care gets major grant 2Health News:Progress Reported in Predicting Alzheimer's 2
(Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
(Date:12/19/2014)... , Dec. 18, 2014 Baptist Health Lexington is ... to receive full Atrial Fibrillation with Electrophysiology Services (EPS) ... Atrial fibrillation is the most common cardiac arrhythmia ... some cases can lead to stroke and possible death. More ... have atrial fibrillation and the numbers are rapidly ...
(Date:12/19/2014)... membrane market has witnessed robust development with the growth pace ... later starter. In 2012, the size of China ... the proportion worldwide soaring to 16.3%. It is projected that ... its growth rate by around 20% in the upcoming years ... RMB25 billion. An integrated membrane industrial system has ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... 2011 Nephros, Inc. (OTC Bulletin Board: NEPHD ... for therapeutic applications, infection control, and water purification, announced today ... December 31, 2010. 2010 Highlights ... prior year period Increased gross margin by 22% to ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a proposal to the Board of Directors of Cephalon, ... for $73.00 per share in cash.  The proposal, valued ... 29% over Cephalon,s 30-day trading average.  Valeant announced its ...
Cached Medicine Technology:Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 2Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 3Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 4Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 5Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 6Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 7Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 8Nephros Reports 2010 Fourth Quarter and Full Year Financial Results 9Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 2Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 3Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 4Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 5Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 6Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 7Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 8Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 9Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 10Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 11Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash 12